Bausch & Lomb Surgical, Inc. recalls enVista one-piece hydrophobic acrylic toric intraocular lens, Bausch and Lomb - Product Usage: is indicated for primary…
- Recall date
- June 9, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2552-2020
- FDA classification
- Class II
- Brand / firm
- Bausch & Lomb Surgical, Inc.
- Sold / distributed
- U.S. Nationwide distribution including in the states of IN, SC, CT, NV, and NC.
Why it was recalled
The toric axis marks were misaligned (from the expected position in relation to the haptics) on an implanted lens.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
enVista one-piece hydrophobic acrylic toric intraocular lens, Bausch and Lomb - Product Usage: is indicated for primary implantation in the capsular bag of the eye in adult patients for visual correction of aphakia and corneal astigmatism following removal of a cataractous lens for improved uncorrected distance vision.
Get recall alerts
Free email alert whenever Bausch & Lomb Surgical, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bausch & Lomb Surgical, Inc.